Clinical trial
Centralized Gulf States Survey on the Undertreatment of Hypercholesterolemia
NCT01031277 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Centralized Gulf States Survey on the Undertreatment of Hypercholesterolemia
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2009
- Completion date
- July 31, 2010
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.